By staff writers

August 27, 2015 -- Radiation oncology firm Elekta is highlighting a consortium it created to continue to develop the use of linear accelerator technologies for brain diseases.

The Elekta Linac-based Brain Stereotactic Radiation Therapy (SRT) Consortium's first priorities are to establish a linac-based SRT database; conduct research on practice patterns, contouring methods, and treatment-planning strategies; and publish large studies that investigate dose/fractionation, histology, local control and survival, and other parameters, the company said.

The group's founding members are Massachusetts General Hospital, Odette Cancer Centre at Sunnybrook Health Sciences Centre, the University of Iowa, and University Medical Center in Mannheim, Germany. Its first meeting was held on July 9 in Boston.

Copyright © 2015

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking